Takeda Biopharmaceuticals India Private Limited presented its cutting-edge digital innovations at the G20 Health Working Group meeting held in Goa, India, from April 17th to April 19th. The event’s focus was on creating a digital health ecosystem, discussing innovations in healthcare, exploring how technology can aid continuing care, and providing digital public health goods. Takeda Biopharmaceuticals showcased its digital solutions, including MyPKFit, Synapse, and Athena, at the event.
MyPKFit is an FDA-approved application that offers personalized and interactive prophylaxis treatment options. Synapse is a platform designed to enhance awareness and knowledge-sharing among healthcare professionals, engaging over 4000 healthcare professionals through scientific exchange and educational initiatives. The Athena App MVP is a digital health solution that empowers patients to easily track, understand, and communicate simple, robust measures of Quality of Life (QOL).
Takeda Biopharmaceuticals’ digital innovations aim to improve patient outcomes, enhance healthcare access, and optimize standards of care. Through their participation in the G20 Health Working Group meeting, they aim to collaborate with G20 member countries and relevant international organizations, explore potential collaborations, and drive digital health innovation and adoption. Takeda Biopharmaceuticals is committed to leveraging digital solutions to transform healthcare and provide better health and a brighter future.
